QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Semba, R. D. Articles by Osterhaus, A. Search for Related Content PubMed PubMed Citation Articles by Semba, R. D. Articles by Osterhaus, A.

---

Research Communication

Integration of Vitamin A Supplementation with the Expanded Program on Immunization Does Not Affect Seroconversion to Oral Poliovirus Vaccine in Infants¹

Richard D. Semba², Muhilal^*, Nasrin E. G. Mohgaddam, Zakiuddin Munasir^**, Arwin Akib^**, Dewi Permaesih^*, Muherdiyantiningsih^* and Albert Osterhaus

Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, MD 21287; ^* Nutrition Research and Development Centre, Ministry of Health, Bogor, Indonesia; National Institute of Public Health and the Environment, Bilthoven, The Netherlands; ^** Department of Paediatrics and Child Health, University of Indonesia, Jakarta, Indonesia; and Department of Virology, Erasmus University, Rotterdam, The Netherlands

²To whom correspondence should be addressed.

Childhood immunization programs may provide infrastructure for delivering vitamin A supplements to infants in developing countries. The effect of giving vitamin A, an immune enhancer, on antibody responses to trivalent oral poliovirus vaccine (TOPV) is unknown. A randomized, double-blind, placebo-controlled clinical trial was conducted to determine the effect of giving vitamin A simultaneously with TOPV on antibody responses to poliovirus. Infants (n = 467) received oral vitamin A, 15 mg retinol equivalent (RE), 7.5 mg RE or placebo with TOPV at 6, 10 and 14 wk of age. Antibody responses to poliovirus types 1, 2 and 3 were measured by a microvirus neutralization assay at enrollment and at 9 mo of age. Seroconversion rates to poliovirus types 1, 2 and 3 ranged from 98 to 100% in the three treatment groups, and there were no differences in mean antibody titers to poliovirus types 1, 2 and 3 among treatment groups. This study demonstrates that oral vitamin A does not affect antibody responses to poliovirus vaccine when integrated with the Expanded Program on Immunization.

KEY WORDS: • infants • vitamin A • immunization • poliovirus • vaccine

This article has been cited by other articles:

				M. Savy, K. Edmond, P. E. M. Fine, A. Hall, B. J. Hennig, S. E. Moore, K. Mulholland, U. Schaible, and A. M. Prentice Landscape Analysis of Interactions between Nutrition and Vaccine Responses in Children J. Nutr., November 1, 2009; 139(11): 2154S - 2218S. [Abstract] [Full Text] [PDF]

				S. Newton, S. Cousens, S. Owusu-Agyei, S. Filteau, C. Stanley, L. Linsell, and B. Kirkwood Vitamin A Supplementation Does Not Affect Infants' Immune Responses to Polio and Tetanus Vaccines J. Nutr., November 1, 2005; 135(11): 2669 - 2673. [Abstract] [Full Text] [PDF]

				E. Villamor and W. W. Fawzi Effects of Vitamin A Supplementation on Immune Responses and Correlation with Clinical Outcomes Clin. Microbiol. Rev., July 1, 2005; 18(3): 446 - 464. [Abstract] [Full Text] [PDF]